Cargando…
A retrospective analysis of clinical outcomes between hospitalized patients with COVID‐19 who received famotidine or pantoprazole
BACKGROUND AND AIM: There is limited research on the use of histamine‐H2 receptor antagonists and proton pump inhibitors for treating COVID‐19. We compare clinical outcomes between patients hospitalized with COVID‐19 receiving famotidine or pantoprazole. METHODS: This retrospective study included 21...
Autores principales: | Wagner, Justin J., St. Cyr, Nikolas, Douen, Aaron, Fogel, Joshua, Trillo, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366487/ https://www.ncbi.nlm.nih.gov/pubmed/37496815 http://dx.doi.org/10.1002/jgh3.12905 |
Ejemplares similares
-
No Pharmacokinetic Interaction Between the Hepatitis C Virus Inhibitors Elbasvir/Grazoprevir and Famotidine or Pantoprazole
por: Feng, H‐P, et al.
Publicado: (2017) -
A Prospective Randomized Trial of Either Famotidine or Pantoprazole for the Prevention of Bleeding after Endoscopic Submucosal Dissection
por: Jeong, Hye-Kyong, et al.
Publicado: (2007) -
A Retrospective Clinical Investigation of the Safety and Adverse Effects of Pantoprazole in Hospitalized Ruminants
por: Smith, Joseph S., et al.
Publicado: (2020) -
Environmentally Benign and Facile Process for the
Synthesis of Pantoprazole Sodium Sesquihydrate: Phase Transformation
of Pantoprazole Sodium Heterosolvate to Pantoprazole Sodium Sesquihydrate
por: Awasthi, Arun Kumar, et al.
Publicado: (2017) -
Comparison of macroscopic abnormalities in patients receiving routine pantoprazole when compared to placebo
por: Summers, MJ, et al.
Publicado: (2015)